Product Information
MEMANTINE HCL ER 14 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3391 per EA under NDC 16571085309. Its NADAC has been published 36 times since Dec 17, 2025.
FDA first approved this application on Sep 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the memantine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
14 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571085309
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206032FDA Approved
9/28/2016
TE Code
AB
On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL ER 14 MG CAPSULE has been published 36 times since Dec 17, 2025, and over the history we have for it it has risen 11.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3391 per EA |
|---|---|
| All-time high | $0.3391 (Aug 19, 2026) |
| All-time low | $0.2748 (Feb 18, 2026) |
| 52-week high | $0.3391 |
| 52-week low | $0.2748 |
| Median price | $0.3127 |
| Average price | $0.3088 |
| Largest weekly change | +11.4% (Mar 18, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEMANTINE HCL ER 14 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL ER 14 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.3391 per EA (NDC 16571085309), effective Aug 19, 2026.
How has the price of MEMANTINE HCL ER 14 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL ER 14 MG CAPSULE has risen 11.5%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL ER 14 MG CAPSULE?
Since Dec 17, 2025, the NADAC for MEMANTINE HCL ER 14 MG CAPSULE has ranged from a low of $0.2748 (Feb 18, 2026) to a high of $0.3391 (Aug 19, 2026), with a median of $0.3127 per EA.
Are there cheaper alternatives to MEMANTINE HCL ER 14 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEMANTINE HCL ER 14 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MEMANTINE HCL ER 14 MG CAPSULE?
MEMANTINE HCL ER 14 MG CAPSULE (NDC 16571085309) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.